港股午評:三大指數齊跌 科技股弱勢 鋼鐵股回調 創新藥概念股繼續強勢
港股上午盤三大指數持續走低,盤中跌幅均超1.2%以上,市場情緒低迷。截止午盤,恒生指數跌0.96%再度跌破24000點整數關口,國企指數、恒生科技指數分別下跌1.24%及1.2%。盤面上, 作為市場風向標的大型科技股集體表現弱勢,尤其是小米跌4.5%,阿里巴巴跌3.5%,美團跌超2%,京東、快手、騰訊皆下跌;昨日午後大幅飆升的鋼鐵股回調明顯,重慶鋼鐵股份跌超12%,馬鞍山鋼鐵、鞍鋼股份跟跌;新消費概念股亦集體走低,奈雪的茶跌超10%,泡泡瑪特、蜜雪集團、老鋪黃金均下跌;教育股、軟件類股、內銀股、餐飲股、影視娛樂股紛紛下跌。另一方面,生物醫藥類股繼續活躍,尤其是創新藥概念股方向升勢明顯,華昊中天醫藥繼續升超17%,康方生物升超11%,信達生物、再鼎醫藥、中國生物製藥跟升,蘋果概念股、核電股、石油股、黃金股多數上升,濠賭股繼續升勢。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.